Eni U E, Ekwedigwe K C, Sunday-Adeoye I, Daniyan Abc, Isikhuemen M E
Department of Surgery, Federal Teaching Hospital, Abakaliki, Nigeria.
National Obstetric Fistula Centre, Abakaliki, Nigeria.
World J Surg Oncol. 2017 Mar 7;15(1):56. doi: 10.1186/s12957-017-1122-7.
Breast cancer is the leading cancer in women in both developed and developing countries. Screening mammography detects breast cancer even before a lump can be palpated, with better prognosis. The introduction of mammographic technique for screening breast cancer, despite its importance, has been slow to adopt and virtually non-existent in many parts of Sub-Saharan Africa including Nigeria. For this reason, the indications of mammography have not been well defined in our setting. The aim of this study was to audit our mammography requests, with a view to improving its application in our setting.
This is a descriptive study carried out on 69 female patients who had mammography at the National Obstetric Fistula Centre, Abakaliki, from January 2014 to December 2015. Findings on clinical examination were entered in a proforma. Mammography was performed in craniocaudal and mediolateral views using the Lorad M-IV (film-screen) mammography machine. Data was analysed using the Statistical Package for Social Sciences (SPSS) version 21.
All 69 patients were females. Their mean age was 42.1 ± 11 years. Majority of the patients (69.6%) were between 30 and 49 years. The commonest indication for mammography was breast lump which was found in 46 patients (66.7%). Breast pain was present in 36 (52.2%) of patients. The different Breast Imaging Reporting and Data System (BIRADS) categories were BIRADS 0: 20 (28.99%), BIRADS 1: 8 (11.59%), BIRADS 2: 9 (13.04%), BIRADS 3: 4 (5.8%), BIRADS 4: 19 (27.54%) and BIRADS 5: 9 (13.04%).
Diagnostic mammography remains the commonest indication for mammography in our setting. Public awareness, poverty reduction and ready availability of mammography facilities are required to improve screening mammography in our setting.
在发达国家和发展中国家,乳腺癌都是女性中最主要的癌症。乳腺钼靶筛查甚至在可触及肿块之前就能检测出乳腺癌,预后更好。尽管乳腺钼靶技术对乳腺癌筛查很重要,但在包括尼日利亚在内的撒哈拉以南非洲许多地区,其采用速度缓慢,实际上几乎不存在。因此,在我们的环境中,乳腺钼靶检查的适应症尚未得到明确界定。本研究的目的是审核我们的乳腺钼靶检查申请,以改善其在我们环境中的应用。
这是一项描述性研究,对2014年1月至2015年12月在阿巴卡利基国家产科瘘管中心接受乳腺钼靶检查的69名女性患者进行。临床检查结果记录在一份表格中。使用Lorad M-IV(胶片-屏)乳腺钼靶机进行头尾位和内外侧斜位乳腺钼靶检查。数据使用社会科学统计软件包(SPSS)21版进行分析。
所有69名患者均为女性。她们的平均年龄为42.1±11岁。大多数患者(69.6%)年龄在30至49岁之间。乳腺钼靶检查最常见的适应症是乳腺肿块,46名患者(66.7%)有此症状。36名(52.2%)患者存在乳房疼痛。不同的乳腺影像报告和数据系统(BIRADS)分类为:BIRADS 0:20例(28.99%),BIRADS 1:8例(11.59%),BIRADS 2:9例(13.04%),BIRADS 3:4例(5.8%),BIRADS 4:19例(27.54%),BIRADS 5:9例(13.04%)。
在我们的环境中,诊断性乳腺钼靶检查仍然是乳腺钼靶检查最常见的适应症。需要提高公众意识、减少贫困并提供现成的乳腺钼靶检查设施,以改善我们环境中的筛查性乳腺钼靶检查。